Get started
Author

Gavin Reilly

Observed names: G Reilly, Gavin S. Reilly
OpenAlex ID: A5057359239
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
2018 · Janusz A Z Jankowski, John de Caestecker, et al. · The Lancet · 267
PDF
Perioperative and oncological outcomes of radical prostatectomy for high‐risk prostate cancer in the UK: an analysis of surgeon‐reported data
2019 · Jonathan J. Aning, Gavin S. Reilly, et al. · British Journal of Urology · 17
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.
2018 · Janusz Jankowski, John de Caestecker, et al. · Journal of Clinical Oncology · 2
SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins.
2018 · Daniel Holyoake, Maxwell Robinson, et al. · Journal of Clinical Oncology
PDF
PWE-124 Daily aspirin 300mg: how much do patients take? drug accountability for the first 5 years of the aspect study
2017 · J Jankowski, S Love, et al. · Gut
Weekly carboplatin/paclitaxel (CP) based definitive chemoradiotherapy (dCRT) for patients with inoperable oesophageal cancer unsuitable for cisplatin-fluoropyrimidine based dCRT: A single centre experience
2017 · Robert Owens, Nicola Warner, et al. · Annals of Oncology
PDF
The changing world of clinical trials 2003-2017: A view from the AspECT trial
2017 · Gavin Reilly, Love Sbl., et al.
Barrett's oesophagus patients attending hospital: Baseline clinical, patient history and quality of life data from BOSS and AspECT
2016 · Sharon Love, Gavin Reilly, et al. · European Journal of Surgical Oncology
PTU-149 Barrett’s Oesophagus Patients Attending Hospital: Baseline Clinical, Patient History and Quality of Life Data from Boss and Aspect
2016 · S Love, G Reilly, et al. · Gut
Works count: 9
Citation count: 286
H-index: 2
I10-index: 2
Year
Topic
Type